Circulating Nucleic Acids in Serum and Plasma – CNAPS IX

Chapter 1 Circulating Cell-Free miR-373, miR-200a, miR-200b and miR-200c in Patients with Epithelial Ovarian Cancer.

Chapter 2 Circulating Nucleic Acids in Serum and Plasma – CNAPS IX

Chapter 3 Clinical Utility of Circulating Tumor DNA for Molecular Assessment and Precision Medicine in Pancreatic Cancer.

Chapter 4 An Enquiry Concerning the Characteristics of Cell-Free DNA Released by Cultured Cancer Cells.

Chapter 5 Detection of p53 Mutations in Circulating DNA of Transplanted Hepatocellular Carcinoma Patients as a Biomarker of Tumor Recurrence.

Chapter 6 Circulating Nucleic Acids in Serum and Plasma – CNAPS IX

Chapter 7 Liquid Profiling in Lung Cancer - Quantification of Extracellular miRNAs in Bronchial Lavage.

Chapter 8 Screening of KRAS Mutation in Pre- and Post-Surgery Serum of Patients Suffering from Colon Cancer by COLD-PCR HRM.

Chapter 9 Non-dividing Cell Virtosomes Affect In Vitro and In Vivo Tumour Cell Replication.

Chapter 10 Features of Circulating DNA Fragmentation in Blood of Healthy Females and Breast Cancer Patients.

Chapter 11 Liquid Profiling of Circulating Nucleic Acids as a Novel Tool for the Management of Cancer Patients.

Chapter 12 Characterization of Human Pregnancy Specific Glycoprotein (PSG) Gene Copy Number Variations in Pre-eclampsia Patients.

Chapter 13 Non-invasive Prenatal Diagnosis of Feto-Maternal Platelet Incompatibility by Cold High Resolution Melting Analysis.

Chapter 14 Implementing Non-Invasive Prenatal Diagnosis (NIPD) in a National Health Service Laboratory; From Dominant to Recessive Disorders.

Chapter 15 Comparative Analysis of Harmful Physical Factors Effect on the Cell Genome.

Chapter 16 Heterochromatic Tandem Repeats in the Extracellular DNA.

Chapter 17 A Historical and Evolutionary Perspective on Circulating Nucleic Acids and Extracellular Vesicles: Circulating Nucleic Acids as Homeostatic Genetic Entities.

Chapter 18 Comparison of MicroRNA Content in Plasma and Urine Indicates the Existence of a Transrenal Passage of Selected MicroRNAs.

Chapter 19 A Quantitative Assessment of Cell-Free DNA Utilizing Several Housekeeping Genes: Measurements from Four Different Cell Lines.

Chapter 20 Oligodeoxynucleotide Analogues of Circulating DNA Inhibit dsRNA-Induced Immune Response at the Early Stages of Signal Transduction Cascade in a Cell Type-Dependent Manner.

Chapter 21 GC-Rich DNA Fragments and Oxidized Cell-Free DNA Have Different Effects on NF-kB and NRF2 Signaling in MSC.

Chapter 22 Evaluation of the State of Transplanted Liver Health by Monitoring of Organ-Specific Genomic Marker in Circulating DNA from Receptor.

Chapter 23 Vesicular and Extra-Vesicular RNAs of Human Blood Plasma.

Chapter 24 Artificial Analogues of Circulating Box C/D RNAs Induce Strong Innate Immune Response and MicroRNA Activation in Human Adenocarcinoma Cells.

Chapter 25 Multiple Ways of cfDNA Reception and Following ROS Production in Endothelial Cells.

Chapter 26 Protein Content of Circulating Nucleoprotein Complexes.

Chapter 27 Digital PCR of Genomic Rearrangements for Monitoring Circulating Tumour DNA.

Chapter 28 mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNA.

Chapter 29 Methodological Variables in the Analysis of Cell-Free DNA.

Chapter 30 Novel Technology for Enrichment of Biomolecules from Cell-Free Body Fluids and Subsequent DNA Sizing.

Chapter 31 A Rapid and Sensitive Method for Detection of the T790M Mutation of EGFR in Plasma DNA.

Chapter 32 Evaluation of Different Blood Collection Tubes and Blood Storage Conditions for the Preservation and Stability of Cell-Free Circulating DNA for the Analysis of the Methylated (m)SEPT9 Colorectal Cancer Screening Marker.

Chapter 33 Purification of Circulating Cell-Free DNA from Plasma and Urine Using the Automated Large-Volume Extraction on the QIAsymphony® SP Instrument.

Chapter 34 Detection and Quantification of KIT Mutations in ctDNA by Plasma Safe-SeqS.

Chapter 35 Lost in Translation? Ethical Challenges of Implementing a New Diagnostic Procedure.

Chapter 36 Academia Meets Industry.